NSE · ASTERDM.NS
Aster DM Healthcare Limited
₹680.00+₹0.80 (+0.12%)
Aster DM Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 23.71% below the high.
Loading market information…
NSE · HCG.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:13 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
HealthCare Global Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 24.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
HealthCare Global Enterprises Limited’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of ₹2.27. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow HealthCare Global Enterprises Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HealthCare Global Enterprises Limited, founded in 1989 and headquartered in Bengaluru, India, delivers comprehensive healthcare services with a primary focus on oncology. The company offers a full spectrum of cancer care, from diagnosis to various treatment modalities such as radiation therapy, medical oncology, and surgical procedures. Beyond its core cancer services, HCG also operates in the field of fertility and reproductive medicine under its Milann brand. This includes services like assisted reproduction, gynecological endoscopy, and fertility preservation. The enterprise further manages four multi-specialty hospitals: three branded HCG facilities located in Ahmedabad, Bhavnagar, and Rajkot in Gujarat, and one in Hubli, Karnataka, operated under a management contract. These hospitals cater to diverse medical specialities including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonary care, and critical care. Additionally, HealthCare Global provides medical diagnostic services, offering scientific testing and consultancy for the pharmaceutical and broader medical industries. As of March 31, 2021, its extensive network comprised 23 cancer centers throughout India, featuring a center of excellence in Bengaluru, alongside two independent diagnostic centers and one day-care chemotherapy unit. The company also maintains an international presence with a cancer center established in Africa.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2025 | May 24, 2025 | ₹0.50-16.63% vs estimate | ₹5.85B-1.75% vs estimate |
|---|
| Q3 2025 | Feb 14, 2025 | ₹0.60+8.96% vs estimate | ₹5.59B-2.17% vs estimate |
|---|
| Q2 2025 | Nov 9, 2024 | ₹1.28+9.4% vs estimate | ₹5.54B-2.83% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹680.00+₹0.80 (+0.12%)
Aster DM Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 23.71% below the high.
₹1,729.60+₹15.10 (+0.88%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.37% below the high.
₹1,289.50-₹10.20 (-0.78%)
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 16.42% below the high.
₹702.15-₹0.35 (-0.05%)
Krishna Institute of Medical Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 18.16% below the high.
₹939.60+₹16.30 (+1.77%)
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 20.63% below the high.
₹257.80-₹2.30 (-0.88%)
Jupiter Life Line Hospitals Limited’s quoted price sits in the lower half of its reported 52-week range, 24.18% below the high.
₹5,765.50-₹130.50 (-2.21%)
Kovai Medical Center and Hospital Limited’s quoted price sits in the upper half of its reported 52-week range, 10.53% below the high.
₹308.65-₹9.65 (-3.03%)
Indraprastha Medical Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 51.84% below the high.
